Dr. Wang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
520 Country Club Rd
Eugene, OR 97401
Summary
- Dr. Bo Wang is an oncologist in Eugene, OR. He received his medical degree from Albert Einstein COM. He trained at Icahn Mount Sinai School of Medicine for hematology and oncology. Dr. Wang specializes in head & neck cancer, multiple myeloma, and thoracic cancers. Dr. Wang is principal investigator on numerous lung cancer clinical trials.
Education & Training
Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2018 - 2021
Tufts Medical CenterResidency, Internal Medicine, 2015 - 2018
Albert Einstein College of MedicineClass of 2015
Certifications & Licensure
OR State Medical License 2021 - 2025
NY State Medical License 2018 - 2023- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 Start of enrollment: 2020 Dec 02
- Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer Start of enrollment: 2022 Oct 12
- Study of Novel Treatment Combinations in Patients With Lung Cancer Start of enrollment: 2023 Mar 16
- Join now to see all
Publications & Presentations
PubMed
- 1594 citationsAn inflammatory cytokine signature predicts COVID-19 severity and survival.Diane Marie Del Valle, Seunghee Kim-Schulze, Hsin-Hui Huang, Noam D. Beckmann, Sharon Nirenberg
Nature Medicine. 2020-08-24 - 160 citationsHighly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma.Oliver Van Oekelen, Charles R Gleason, Sarita Agte, Komal Srivastava, Katherine Beach
Cancer Cell. 2021-08-09 - 4 citationsOnce-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis.Fieke W Hoff, Fieke W Hoff, Rahul Banerjee, Adeel M Khan, Georgia McCaughan
Blood Cancer Journal. 2024-03-22
Journal Articles
- Chimeric antigen receptor T-cell therapeutics for multiple myeloma: moving into the spotlight.Bo Wang, Sridevi Rajeeve, Deepu Maddur, The Cancer Journal, 4/1/2021
Press Mentions
EVOKE 02 in NSCLCNovember 15th, 2023
COVID-19: Rates of Hospitalization and Mortality Among Patients with Multiple MyelomaAugust 19th, 2020
Committees
- Committee Member, USON Thoracic Research
Professional Memberships
- Member
Other Languages
- Chinese (Mandarin)
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
